Non‐synonymous alterations in AKR7A3 and ABCA6 correlate with bleeding in aged patients treated with rivaroxaban

Rivaroxaban is an oral anticoagulant that inhibits thrombin and blocks coagulation cascade through directly inactivating factors Xa. Despite rivaroxaban is widely used for prevention and treatment of venous thrombosis, and its common adverse reactions have been reported, including abnormal coagulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ming, Zhang, Qiang, Wang, Xizi, Zhang, Qianqian, Tian, Conghui, Li, Rongrong, Jia, Xiaodong, Gu, Mingliang, Yang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010266/
https://www.ncbi.nlm.nih.gov/pubmed/34859601
http://dx.doi.org/10.1111/cts.13205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010266/
https://www.ncbi.nlm.nih.gov/pubmed/34859601
http://dx.doi.org/10.1111/cts.13205

Ejemplares similares